News

Harmonious coexistence with the natural environment

Our strategic goals and adopted performance indicators by 2025 are:

 

1. Reduction of greenhouse gas emissions (CO2 equivalent)

✔ By 2025, we will reduce our carbon footprint in scope 1 and 2 by 17% (compared to 2021)

2. Reducing our environmental impact by eco-designing products and processes and applying the principles of circular economy

✔ We will develop and implement eco-design standards in the process of developing new substances and drugs

✔ We will reduce the amount of waste generated in production and auxiliary processes by 5% in relation to the production volume

 

To achieve our objectives, we are implementing eco-design and closed-loop economy measures and implement environmental education to best care for our common environment.

Read more

Customer-centric approach together with a skilled and experienced team always remains the main priority in managing projects.
Polpharma’s Manufacturing Branch in Duchnice specializes in the production of cephalosporin antibiotics.
In today's post, we introduce Director of Santo CMO Sefi Karayev, who manages the contract projects of Polpharma group production site in Shymkent, Kazakhstan.